Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial
Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.
First personalised cancer vaccine cuts risk of disease returning in major trial
The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.
Personalised skin cancer vaccine cuts risk of disease returning in major trial
The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
Pope Leo needs no further cancer treatment after lung surgery
Tests show the cancer was confined to the portion of the pope’s right lung that was removed, his doctors say. NBC News’ Anne Thompson reports.
Pope Leo’s doctors say he no longer needs cancer treatment after surgery
Pope Leo XIV will not need further treatment following lung cancer surgery, his doctors said. The pontiff suffered pulmonary adenocarcinoma, which was localized and removed. NBC News' Akshay Syal discusses how the pope's medical team will continue…
Pope does not need further treatment after lung cancer surgery
Test results have confirmed his diagnosis as a lung adenocarcinoma that was localised.
Pope Leo requires no further treatment after lung surgery, doctors say
Pope Leo XIV will not need further treatment following lung cancer surgery, his doctors said Wednesday.
Pope Leo will not require further treatment after lung surgery, doctors say
Pope Leo XIV will not need further treatment following lung cancer surgery, his doctors said Wednesday.
OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer
It’s the latest in a growing wave of bets that AI companies are making on brain data.